Cost –utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland

ConclusionAll more invasive strategies were found to increase life expectancy and quality of life of women with aBRCA1 orBRCA2mutation and were cost-saving for the Swiss healthcare system compared to IS.
Source: The European Journal of Health Economics - Category: Health Management Source Type: research